Blue Jet Healthcare Ltd (BLUEJET)
₹504.55
Mkt cap
₹9,531 Cr
P/E ratio
40.60
P/B
6.44
Div yield
0.24%
ROE
19.40%
ROCE
26.10%
EPS (TTM)
₹12.43
Book value
₹78
52W range
325–689
Sector
Healthcare
Price history
Previous close
Incorporated in 1968, Blue Jet Healthcare (earlier called Jet Chemicals Pvt Ltd) is a pharmaceutical and healthcare ingredient & intermediate company and the first manufacturer of saccharin and its salts (artificial sweeteners) in India. [1]
NSE BLUEJETBSE 544009
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthModerate
TechnicalsNeutral
52-week range
−26.72% from high₹505
₹325+55.25% from low₹689
Current
₹504.55
Prev close
₹503.55
Day
+0.20%
Price performance
1D
−0.50%
1W
+5.36%
1M
−8.83%
3M
−18.19%
6M
+12.38%
1Y
−23.03%
YTD
−5.00%
Financials
Revenue, profit & margin
P/E ratio
40.6×
BLUEJET is 18% above the sector median of 34.5×
BLUEJET40.6×
Sector median34.5×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 180 | 181 | 167 | 184 | 163 | 208 | 318 | 340 | 355 | 165 | 192 | 235 | 293 | |
| Expenses | 121 | 119 | 112 | 131 | 119 | 139 | 194 | 200 | 234 | 111 | 146 | 163 | 195 | |
| Operating Profit | 59 | 63 | 55 | 53 | 44 | 69 | 124 | 140 | 121 | 55 | 47 | 71 | 98 | |
| OPM % | 33% | 35% | 33% | 29% | 27% | 33% | 39% | 41% | 34% | 33% | 24% | 30% | 33% | |
| Other Income | 5 | 8 | -3 | 9 | 9 | 12 | 13 | 12 | 8 | 24 | 13 | 23 | 15 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 0 | 1 | 1 | |
| Depreciation | 6 | 6 | 8 | 8 | 3 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 | |
| Profit before tax | 58 | 64 | 44 | 54 | 49 | 77 | 132 | 147 | 123 | 69 | 54 | 87 | 106 | |
| Tax % | 24% | 26% | 27% | 27% | 24% | 24% | 25% | 25% | 26% | 24% | 25% | 26% | 26% | |
| Net Profit | 44 | 48 | 32 | 40 | 38 | 58 | 99 | 110 | 91 | 52 | 40 | 64 | 78 | |
| EPS in Rs | 2.54 | 2.76 | 1.85 | 2.29 | 2.18 | 3.36 | 5.71 | 6.35 | 5.26 | 3.01 | 2.32 | 3.71 | 4.51 | |
| Raw PDF |
Earnings
Results dates & reactionsNext results
5 Nov '26
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −5.87% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 3 Aug '26 |
| Earnings day | −5.87% |
| +1 day | −7.06% |
| +5 days | −5.45% |
| +15 days | −5.98% |
| +30 days | −12.07% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202673.15%Promoter
Promoters73.15%6.66
FIIs0.81%0.41
DIIs7.48%2.83
Public18.56%3.42
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,761.00 | 33.45 | 4,22,523 | 0.91% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| Divi's Lab. | ₹9,664.00 | 86.11 | 2,56,549 | 0.31% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,580.00 | 80.24 | 1,74,208 | 0.83% | 534 | −10.03% | 4,979 | +50.79% | 15.19% |
| Laurus Labs | ₹2,244.00 | 90.49 | 1,21,246 | 0.09% | 436 | +126.43% | 2,206 | +33.44% | 17.76% |
| Zydus Lifesci. | ₹1,184.40 | 24.27 | 1,18,144 | 0.08% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Dr Reddy's Labs | ₹1,345.00 | 40.10 | 1,12,265 | 0.59% | 913 | −31.35% | 8,698 | −1.48% | 13.04% |
| Cipla | ₹1,358.00 | 35.33 | 1,09,709 | 0.96% | 852 | −35.05% | 7,404 | −2.44% | 15.49% |
| Blue Jet Health | ₹503.55 | 40.57 | 9,531 | 0.24% | 78 | −14.16% | 293 | −17.38% | 26.07% |
| Median: 159 Co. | ₹439.10 | 34.49 | 1,934 | 0.08% | 14 | +22.88% | 170 | +18.91% | 15.11% |
Filings
Annual reports3
Concall transcripts31
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptJul 2025PPTJul 2025RECJul 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024PPTOct 2024TranscriptAug 2024PPTAug 2024
Credit ratings2
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 29 Oct - Intimation of Analyst and Investor call under Regulation 30 of the SEBI (LODR) Regulations, 2015 scheduled to be held on 5th November, 2026Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On 5Th November, 2026 Of The Company 29 Oct - Board meeting on November 5, 2026 to consider Q2/H1 FY27 unaudited results; trading window reopens November 8.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Oct - Submitted Regulation 74(5) compliance certificate for quarter ended September 30, 2026; no rematerialisation requests.Closure of Trading Window 24 Sep - Trading window closed from October 1, 2026 until 48 hours after Q2 FY27 results.Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 22 Sep - Blue Jet Healthcare announced 58th AGM voting results, including Rs 1.20 dividend and director reappointments.